ÂÜÀòÂÒÂ×

Andreas Inmann, PhD, MBA, is a seasoned leader in the medical device industry, currently serving as President & COO and Co-Founder of LucyDx, focused on preventing blindness in diabetics through early detection since 2021, and as President & CEO and Co-Founder of O2 RegenTech, which provides cost-effective wound care solutions using proprietary biomaterials since 2015. Andreas Inmann also operates Andreas Inmann Consulting, offering expertise to medical device entrepreneurs and institutions while reviewing opportunities in the field. Previous roles include Director of Product Development at NDI Medical where strategic developments led to successful spin-offs, and senior positions at MetaCure and Advanced Bionics Corporation, pioneering neurostimulation technologies. Educational credentials include a PhD from Aalborg University, an MBA from Regis University, and a Dipl. Ing. in Electrical Engineering from Technische Universität Wien.